Role of Prasugrel, a Novel P2Y 12 Receptor Antagonist, in the Management of Acute Coronary Syndromes

Author： Baker William L. White C. Michael

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.9, Iss.4, 2009-08, pp. : 213-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prasugrel: a novel platelet ADP P2Y₁₂ receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J Suryadevara Siva Capranzano Piera Bass Theodore A

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite

Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1805-1812

Bentham Science Publishers

Access to resources Recommend Favorite

Importance of potent P2Y₁₂ receptor blockade in acute myocardial infarction: focus on prasugrel

By Jeong Young-Hoon Tantry Udaya S Gurbel Paul A

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1771-1796

Informa Healthcare

Access to resources Recommend Favorite

Prasugrel a strong contender in acute coronary syndromes

Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

The role of antiplatelet therapy in the management of acute coronary syndromes

By Volturo Gregory A Mazzola Jennifer L Przylenk Karin

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 541-556

Informa Healthcare

Access to resources Recommend Favorite